Summary:
A randomized, double blind placebo controlled study of the efficacy and safety of Welchol as monotherapy for Ytpe 2 diabetes mellitus
Qualified Participants Must:
• Have diabetes
Age 18 and older
No history of cancer
Has not been on any diabetic meds for at least 3 months.
Qualified Participants May Receive:
Travel reimbursement
Diabetics supplies
Labwork
Physical by physician